Accretion Nutraveda Ltd vs Kobo Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Accretion Nutraveda Ltd is ₹ 272 as of 15 May 15:30 . The P/E Ratio of Accretion Nutraveda Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Kobo Biotech Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Accretion Nutraveda Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Kobo Biotech Ltd changed from ₹ 17.63 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 5 years The Revenue of Accretion Nutraveda Ltd is ₹ 0 crore as of Jun '24 .The Revenue of Kobo Biotech Ltd is ₹ 0.02 crore as of Jun '24 . The EBITDA of Accretion Nutraveda Ltd is ₹ 0 crore as of Jun '24 .The EBITDA of Kobo Biotech Ltd is ₹ -0.32 crore as of Jun '24 . The Net Profit of Accretion Nutraveda Ltd is ₹ 0 crore as of Jun '24 .The Net Profit of Kobo Biotech Ltd is ₹ -1.33 crore as of Jun '24 . The Dividend Payout of Accretion Nutraveda Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Kobo Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Accretion Nutraveda Ltd

Accretion Nutraveda Limited was initially incorporated as a Private Limited Company on March 16, 2021 and has subsequently, converted the status into a Public Limited Company vide Certificate of Incorporation issued by the Registrar of Companies, Central Processing Centre w.e.f.
May 2, 2025. The Company, established at Ahmedabad, is a healthcare-focused Contract Development and Manufacturing Organization (CDMO), offering specialized services to a diverse range of clients across the various industries.
It specialize in ayurvedic and nutraceutical products including Tablets, Capsules, Oral Liquids, Oral Powders, External Preparation and Oils.
Apart from these, it offer a diverse range of dosage forms, leveraging both Classical Ayurvedic principles and modern nutraceutical science. The products include Tablets, such as film-coated and chewable varieties, for applications in liver care, gynecological care, bone and joint health, and respiratory support.

About Kobo Biotech Ltd

Kobo Biotech Ltd.(Formerly known Avon Lifesciences Ltd) was established as a Public Limited Company on August 3, 1992.
Effective 19th October, 2020, the Company's name was changed to Kobo Biotech Limited from erstwhile Avon Lifesciences Limited.
The Company is a customer-centric manufacturer of active pharmaceutical ingredients (API).Promoted by P R Agarwal, Rajesh Agarwal and G S Sidhu, the Company manufacture diketene and its derivatives Monomethyl Acetoncetamide(MMA) and Methyl Acetoacetate(MAA). The company's 1200 tpa Diketene manufacturing faciltiy located at Sadashivpet in Andhrapradesh and the products of it were used in pigments, pharmaceuticals and pesticides. The company has a tripartite technical knowhow agreement with Shanghai Machinery & Equipment Import and Export Corporation (SMEC), representative of Shanghai Peng Pu Chemical Works (SPCW) and Xytel Technologies Partnership (XTP), US.

FAQs for the comparison of Accretion Nutraveda Ltd and Kobo Biotech Ltd

Which company has a larger market capitalization, Accretion Nutraveda Ltd or Kobo Biotech Ltd?

Market cap of Accretion Nutraveda Ltd is 196 Cr while Market cap of Kobo Biotech Ltd is 6 Cr

What are the key factors driving the stock performance of Accretion Nutraveda Ltd and Kobo Biotech Ltd?

The stock performance of Accretion Nutraveda Ltd and Kobo Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Accretion Nutraveda Ltd and Kobo Biotech Ltd?

As of May 18, 2026, the Accretion Nutraveda Ltd stock price is INR ₹272.0. On the other hand, Kobo Biotech Ltd stock price is INR ₹2.58.

How do dividend payouts of Accretion Nutraveda Ltd and Kobo Biotech Ltd compare?

To compare the dividend payouts of Accretion Nutraveda Ltd and Kobo Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.